The application of autoantibodies detection in the early diagnosis and screening of lung cancer
10.3760/cma.j.cn112434-20200429-00237
- VernacularTitle:自身抗体检测在肺癌早期诊断筛查中的应用
- Author:
Weidong WANG
1
;
Tianyu HE
;
Liang PAN
;
Xiuyi ZHI
;
Jian HU
Author Information
1. 浙江大学附属第一医院胸外科，杭州 310003
- From:
Chinese Journal of Thoracic and Cardiovascular Surgery
2021;37(7):433-437
- CountryChina
- Language:Chinese
-
Abstract:
Lung cancer is the malignant tumor with the highest morbidity and mortality worldwide, most lung cancer patients were diagnosed at an advanced stage. Using low-dose computed tomography(CT) for lung cancer screening in high-risk patients were proved to decrease lung cancer mortality and find out more early-stage patients. However, CT is of high false-positive rate which requires long-term follow-up or invasive examination to confirm the diagnosis. Serum tumor markers have become the focus of early diagnosis of lung cancer due to their characteristics of minimally invasive and good stability. Lung cancer-related antigens can be captured by the immune system to produce autoantibodies. These autoantibodies can appear in the early stage of lung cancer development with high concentration and stably exist. Therefore, the detection of serum autoantibodies can be effective in the early screening and early diagnosis of lung cancer. Here, we provide a systematic review of the production and detection methods of tumor autoantibodies and their application in the diagnosis and screening of malignant tumors, especially lung cancer.
